Mesenchymal stem cell-derived small extracellular vesicles as a delivery vehicle of oncolytic reovirus

This study demonstrates that sEVs-reo can address key challenges associated with oncolytic virotherapy. These findings support potential of sEVs as a novel and effective DDS for reovirus in colon cancer treatment, while offering a versatile platform to enhance the efficacy of other oncolytic viruses.